Chromogranin a as a possible tool in the diagnosis of irritable bowel syndrome

Scandinavian Journal of Gastroenterology

Volumn 45, Issue 12, 2010, Pages 1435-1439

  El Salhy, Magdy ^a,c   Lomholt Beck, Bjarne ^b   Hausken, Trygve ^c  

^a Stord Helse Fonna Hospital   (Norway)

^b Haugesund Helse Fonna Hospital   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Computer image analysis; Endocrine cells; IBS; Immunohistochemistry; Intestine

Indexed keywords

CD16 ANTIGEN; CHROMOGRANIN A;

ADULT; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; COLON BIOPSY; COLONOSCOPY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DUODENUM BIOPSY; ENTEROENDOCRINE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROSCOPY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHROMOGRANIN A; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED;

EID: 78649244540     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2010.503965     Document Type: Article

References (16)

1. Thompson WG. A world view of IBS. In: Camilleri M, Spiller R, editors. Irritable bowel syndrome: diagnosis and treatment. Philadelphia and London: Saunders; 2002. pp 17-26.
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U. S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
3. Hugin AP, Whonwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40, 000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
4. Wilson S, Roberts L, Roalfe A, Bridge P, Sukhdev S. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004;54:495-502.
5. Whitehead WE, Burnett CK, Cook EW III, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996;41:2248-53.
6. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disord. Gastroenterology 2006;130:1480-91.
7. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003;348:1134-49.
8. Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocr Rev 1991;12:181-8.
9. Wicdenmann B, Huttner WB. Synaptophysin and Chromogranin/secretogranins- widespread constituents of distinct types of neuroendocrine vesicales and new tools in tumor diagnosis. Virchows Arch B Cell Pathol 1989;58:95-121.
10. Valeur J, Milde AM, Helle KB, Berstad A. Low serum Chromogranin A in patients with self-reported food hypersensitivity. Scand J Gastroenterol 2008;43:1403-4.
11. Sidu R, McAlindon ME, Leeds JS, Skilling J, Sanders DS. The role of serum chromgranin Ain diarrhoea predominant irritable bowel syndrome. J Gastrointestin Liver Dis 2009;18:23-6.
12. Hausken T. The role of Chromogranin A in irritable bowel syndrome. J Gastrointestin Liver Dis 2009;18:259.
13. El-Salhy M, Stenling R, Grimelius L. Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993;28:809-15.
14. Sandström O, El-Salhy M. Aging and endocrine cells of human duodenum. Mech Ageing Dev 1999;108:39-48.
15. Sandström O, El-Salhy M. Human rectal endocrine cells and aging. Mech Ageing Dev 1999;108:219-26.
16. Sjölund K, Sandèn G, Håkanson R, Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983;85:1120-30.